Encouraging results of low-dose etoposide in the treatment of early-onset hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantation [4]

International Journal of Hematology

Volumn 86, Issue 5, 2007, Pages 466-467

  Koyama, Maho ^a   Sawada, Akihisa ^a   Yasui, Masahiro ^a   Inoue, Masami ^a   Kawa, Keisei ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; ETOPOSIDE; FLUDARABINE; IMMUNOGLOBULIN; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; TACROLIMUS; TEPA; THYMOCYTE ANTIBODY;

ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG MEGADOSE; GRAFT VERSUS HOST REACTION; HEMOPHAGOCYTIC SYNDROME; HUMAN; LETTER; LOW DRUG DOSE; PRESCHOOL CHILD; SCHOOL CHILD; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; ETOPOSIDE; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; REMISSION INDUCTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 38349081469     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02984009     Document Type: Letter

References (8)

1. Kawa K. Hemophagocytic syndrome -treatment strategies according to classification and scoring system. In: Education Program Book of the 67th Annual Meeting of the Japanese Society of Hematology and the 47th Annual Meeting of the Japanese Society of Clinical Hematology. Tokyo, Japan; 2005:72-75.
2. Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86:58-65.
3. Levy J, Wodell RA, August CS, Bayever E. Adenovirus-related hemophagocytic syndrome after bone marrow transplantation. Bone Marrow Transplant. 1990;6:349-352.
4. Sato M, Matsushima T, Takada S, et al. Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation. Bone Marrow Transplant. 1998;22:1219-1222.
5. Ishikawa J, Maeda T, Miyazaki T, et al. Early onset of hemophagocytic syndrome following allogeneic bone marrow transplantation. Int J Hematol. 2000;72:243-246.
6. Fukuno K, Tsurumi H, Yamada T, Oyama M, Moriwaki H. Graft failure due to hemophagocytic syndrome after autologous peripheral blood stem cell transplantation. Int J Hematol. 2001;73:262-265.
7. Abe Y, Choi I, Hara K, et al. Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:799-801.
8. Imashuku S, Kuriyama K, Teramura T, et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol. 2001;19:2665-2673.